Repeat biomarker testing (ER/PgR/HER2) in grade three breast carcinoma; not truly necessary.

MedStar author(s):
Citation: Unpublished 2017/10/03Form of publication: Poster PresentationYear: 2017Conference information: MedStar Washington Hospital Center: MedStar Health Research Symposium, North Bethesda, MD., All authors: Holmes MP, Sidawy M, Zeck JFiscal year: FY2018Local accession number: A2017_253Date added to catalog: 2018-08-01
Holdings
Item type Current library Collection Call number Status Date due Barcode
Poster Presentation MedStar Authors Catalog Poster Available

Powered by Koha